NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development-Reference-Cited by-同舟云学术

NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development

Published:2021-02-08 Issue:3 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Tsai Hsiang‐i¹^ORCID,Zeng Xiaobin²³^ORCID,Liu Longshan⁴,Xin Shengchang⁵,Wu Yingyi¹,Xu Zhanxue¹,Zhang Huanxi⁴,Liu Gan¹,Bi Zirong⁴,Su Dandan¹,Yang Min¹,Tao Yijing¹,Wang Changxi⁴,Zhao Jing⁵,Eriksson John E⁶⁷,Deng Wenbin¹,Cheng Fang¹,Chen Hongbo¹^ORCID

Affiliation:

1. School of Pharmaceutical Sciences (Shenzhen) Sun Yat‐Sen University Shenzhen China

2. Center Lab of Longhua Branch and Department of Infectious Disease Shenzhen People's Hospital 2^nd Clinical Medical College of Jinan University Shenzhen China

3. Guangdong Provincial Key Laboratory of Regional Immunity and Diseases Medicine School of Shenzhen University Shenzhen China

4. Organ Transplant Centerm The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

5. State Key Laboratory of Coordination Chemistry Institute of Chemistry and Biomedical Sciences School of Life Sciences Nanjing University Nanjing China

6. Cell Biology Biosciences Faculty of Science and Engineering Åbo Akademi University Turku Finland

7. Turku Centre for Biotechnology University of Turku and Åbo Akademi University Turku Finland

Funder

Sun Yat-sen University

Natural Science Foundation of Guangdong Province

China Postdoctoral Science Foundation

National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers

Publisher

EMBO

Subject

Molecular Medicine

Link